This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schrey, M. P. Articles by Tezapsidis, N. Search for Related Content PubMed PubMed Citation Articles by Schrey, M. P. Articles by Tezapsidis, N.

Bombesin and Glucocorticoids Stimulate Human Breast Cancer Cells to Produce Endothelin, a Paracrine Mitogen for Breast Stromal Cells¹

Unit of Metabolic Medicine, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London W2 1PG, United Kingdom

Human breast cancer cells have been recently reported to produce endothelin (ET) 1. To investigate the potential regulation of ET production in breast cancer cells, we have measured the release of ET-like immunoreactivity from the T47D cell line in response to various paracrine/endocrine factors. Bombesin (0.1 µM) and cortisol (1 µM) stimulated maximal respective increases in IR-ET release to 580 and 369% of basal values after 6 h. The responses to cortisol and bombesin were additive. The response to bombesin was dose dependent with a median effective dose around 1 nM and was inhibited by the receptor antagonist [Leu¹³--CH₂NH-Leu¹⁴]bombesin. Pretreatment of T47D cells with pertussis toxin had no effect on bombesin-induced inositol lipid hydrolysis but inhibited ET-like immunoreactivity release in response to bombesin in the presence of glucocorticoid, by 56%. ET-1 (10 nM) and insulin-like growth factor (10 ng/ml) stimulated modest separate increases in DNA synthesis in human breast fibroblasts of 35 and 71%, respectively, but together exhibited a strong synergistic response to 905% of control values. This in vitro study demonstrates the potential for bombesin and glucocorticoid to regulate ET production in human breast cancer cells, which may in turn have a paracrine influence on neighboring stromal cell function.

¹ This investigation was supported by a grant from the Cancer Research Campaign, United Kingdom.

² To whom requests for reprints should be addressed.

Received 6/20/91. Accepted 1/21/92.

This article has been cited by other articles:

				P. Wulfing, R. Diallo, C. Kersting, C. Wulfing, C. Poremba, A. Rody, R. R. Greb, W. Bocker, and L. Kiesel Expression of Endothelin-1, Endothelin-A, and Endothelin-B Receptor in Human Breast Cancer and Correlation with Long-Term Follow-Up Clin. Cancer Res., September 15, 2003; 9(11): 4125 - 4131. [Abstract] [Full Text] [PDF]

				A. Pedram, M. Razandi, and E. R. Levin Natriuretic Peptides Suppress Vascular Endothelial Cell Growth Factor Signaling to Angiogenesis Endocrinology, April 1, 2001; 142(4): 1578 - 1586. [Abstract] [Full Text]

				A. Bagnato, D. Salani, V. Di Castro, J. R. Wu-Wong, R. Tecce, M. R. Nicotra, A. Venuti, and P. G. Natali Expression of Endothelin 1 and Endothelin A Receptor in Ovarian Carcinoma: Evidence for an Autocrine Role in Tumor Growth Cancer Res., February 1, 1999; 59(3): 720 - 727. [Abstract] [Full Text] [PDF]

				R. R. Ryan, H. C. Weber, W. Hou, E. Sainz, S. A. Mantey, J. F. Battey, D. H. Coy, and R. T. Jensen Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3 J. Biol. Chem., May 29, 1998; 273(22): 13613 - 13624. [Abstract] [Full Text] [PDF]

				K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]

				A. Pedram, M. Razandi, R.-M. Hu, and E. R. Levin Vasoactive Peptides Modulate Vascular Endothelial Cell Growth Factor Production and Endothelial Cell Proliferation and Invasion J. Biol. Chem., July 4, 1997; 272(27): 17097 - 17103. [Abstract] [Full Text] [PDF]